ABOS
Price
$2.24
Change
+$0.01 (+0.45%)
Updated
Sep 25 closing price
Capitalization
161.99M
51 days until earnings call
Intraday BUY SELL Signals
SANA
Price
$2.94
Change
-$0.02 (-0.68%)
Updated
Sep 25 closing price
Capitalization
881.62M
39 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABOS vs SANA

ABOS vs SANA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABOS vs. SANA commentary
Sep 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a StrongBuy and SANA is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
ABOSSANA
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 16 days ago
82%
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
COMPARISON
Comparison
Sep 27, 2026
Stock price -- (ABOS: $2.24 vs. SANA: $2.94)
Brand notoriety: ABOS and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 62% vs. SANA: 88%
Market capitalization -- ABOS: $161.99M vs. SANA: $881.62M
ABOS [@Biotechnology] is valued at $161.99M. SANA’s [@Biotechnology] market capitalization is $881.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.37B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green while SANA’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, SANA is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while SANA’s TA Score has 4 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 6 bearish.
  • SANA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ABOS and SANA are a bad buy in the short-term.

Price Growth

ABOS (@Biotechnology) experienced а -15.47% price change this week, while SANA (@Biotechnology) price change was -5.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.17%. For the same industry, the average monthly price growth was -13.24%, and the average quarterly price growth was +5.35%.

Reported Earning Dates

ABOS is expected to report earnings on Nov 16, 2026.

SANA is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ABOS
Daily Signal:
Gain/Loss:
SANA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
COSW37.171.15
+3.19%
Roundhill COST WeeklyPay ETF (COSW)
VTHR339.231.64
+0.49%
Vanguard Russell 3000 ETF (VTHR)
SIXF35.360.09
+0.26%
AllianzIM U.S. Equity 6 Month Buffer10 Feb/Aug ETF (SIXF)
BKUI49.580.02
+0.04%
BNY Mellon Ultra Short Income ETF (BKUI)
OCIO38.06N/A
N/A
ClearShares OCIO ETF (OCIO)

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with CCXI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then CCXI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+0.22%
CCXI - ABOS
48%
Loosely correlated
+1.64%
NKTX - ABOS
42%
Loosely correlated
-3.51%
RCKT - ABOS
42%
Loosely correlated
-3.53%
EDIT - ABOS
40%
Loosely correlated
-6.18%
SANA - ABOS
39%
Loosely correlated
-0.51%
More